Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Association Between Central Retinal Thickness and Visual Acuity in SCORE Study Patients With Macular Edema due to Retinal Vein Occlusion

Go back to Resources

Association Between Central Retinal Thickness and Visual Acuity in SCORE Study Patients With Macular Edema due to Retinal Vein Occlusion

Authors:

Location:

Go back to Resources

Antigen-Specific T-Lymphocyte Function After Cord Blood Transplantation

Go back to Resources

Antigen-Specific T-Lymphocyte Function After Cord Blood Transplantation

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A Novel Bioerodible Deep Scleral Lamellar Cyclosporine Implant for Uveitis

Go back to Resources

A Novel Bioerodible Deep Scleral Lamellar Cyclosporine Implant for Uveitis

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Effect of Unrelated Donor Marrow Transplantation on Health-Related Qualify of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-cell Depletion Trial)

Go back to Resources

The Effect of Unrelated Donor Marrow Transplantation on Health-Related Qualify of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-cell Depletion Trial)

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME)

Go back to Resources

The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME)

Authors:

Secondary:

Location:

URL:

Go back to Resources

Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report

Go back to Resources

Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Stature in Children With Chronic Kidney Disease: Analysis of NAPRTCS Database

Go back to Resources

Stature in Children With Chronic Kidney Disease: Analysis of NAPRTCS Database

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

Go back to Resources

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema

Go back to Resources

Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Phase II Trial of Celecoxib and Photodynamic Therapy (C-PDT) for Neovascular Age-Related Macular Degeneration

Go back to Resources

Phase II Trial of Celecoxib and Photodynamic Therapy (C-PDT) for Neovascular Age-Related Macular Degeneration

Authors:

Secondary:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 155
  • Page 156
  • Page 157
  • Page 158
  • Current page 159
  • Page 160
  • Page 161
  • Page 162
  • Page 163
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification